沐邦高科
(603398)
| 流通市值：59.24亿 | | | 总市值：74.98亿 |
| 流通股本：3.43亿 | | | 总股本：4.34亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 346,245,891.84 | 1,654,025,846.74 | 1,016,479,848.93 | 640,405,527.71 |
| 营业收入 | 346,245,891.84 | 1,654,025,846.74 | 1,016,479,848.93 | 640,405,527.71 |
| 已赚保费 | - | - | 0 | - |
| 手续费及佣金收入 | - | - | 0 | - |
| 二、营业总成本 | 372,642,493.02 | 1,616,243,999.04 | 986,636,205.84 | 627,926,890.89 |
| 营业成本 | 317,449,440.15 | 1,365,966,520.24 | 810,647,972.52 | 508,546,741.26 |
| 利息支出 | - | - | 0 | - |
| 手续费及佣金支出 | - | - | 0 | - |
| 退保金 | - | - | 0 | - |
| 赔付支出净额 | - | - | 0 | - |
| 提取保险合同准备金净额 | - | - | 0 | - |
| 保单红利支出 | - | - | 0 | - |
| 分保费用 | - | - | 0 | - |
| 税金及附加 | 1,613,480.55 | 8,844,288.25 | 3,639,756.01 | 2,019,002.82 |
| 销售费用 | 3,418,257.55 | 21,802,540.84 | 17,404,443.06 | 12,459,013.74 |
| 管理费用 | 29,227,055.06 | 113,738,497.49 | 98,636,763.66 | 71,357,137.78 |
| 研发费用 | 13,065,348.61 | 65,125,828.69 | 34,580,554.77 | 20,830,618.7 |
| 财务费用 | 7,868,911.1 | 40,766,323.53 | 21,726,715.82 | 12,714,376.59 |
| 其中:利息费用 | 9,179,670.08 | 38,303,796.24 | 19,357,154.57 | 11,169,115.8 |
| 其中:利息收入 | 316,485.17 | 1,040,535.36 | 429,174.2 | -37,036.35 |
| 加:公允价值变动收益 | - | - | 0 | - |
| 加:投资收益 | 0 | 9,779,657.24 | 0 | - |
| 净敞口套期收益 | - | - | 0 | - |
| 汇兑收益 | - | - | 0 | - |
| 资产处置收益 | 0 | 1,472,270.34 | -493,068.61 | -493,068.61 |
| 资产减值损失(新) | 304,691.68 | -17,337,829.26 | -9,799,309.58 | -6,795,315.21 |
| 信用减值损失(新) | 2,457,745.83 | -18,361,139.1 | -4,013,289.93 | -693,540.08 |
| 其他收益 | 5,383,053.61 | 17,916,695.77 | 9,034,140.69 | 8,693,840.44 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -18,251,110.06 | 31,251,502.69 | 24,572,115.66 | 13,190,553.36 |
| 加:营业外收入 | 36,235.58 | 545,798.5 | 434,196.71 | 429,310.21 |
| 减:营业外支出 | 133,131.55 | 2,139,246.44 | 944,423.7 | 562,834.87 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -18,348,006.03 | 29,658,054.75 | 24,061,888.67 | 13,057,028.7 |
| 减:所得税费用 | 14,967,074.44 | 3,181,538.74 | 8,975,263.74 | 1,833,633.47 |
| 六、净利润 | -33,315,080.47 | 26,476,516.01 | 15,086,624.93 | 11,223,395.23 |
| 持续经营净利润 | -33,315,080.47 | 26,476,516.01 | 15,086,624.93 | 11,223,395.23 |
| 终止经营净利润 | - | - | 0 | - |
| 归属于母公司股东的净利润 | -32,708,167.29 | 28,288,283.49 | 15,988,537.87 | 11,482,340.18 |
| 少数股东损益 | -606,913.18 | -1,811,767.48 | -901,912.94 | -258,944.95 |
| (一)基本每股收益 | -0.1 | 0.08 | 0.05 | 0.03 |
| (二)稀释每股收益 | -0.1 | 0.08 | 0.05 | 0.03 |
| 八、其他综合收益 | - | 0 | 0 | - |
| 归属于母公司股东的其他综合收益 | - | - | 0 | - |
| 九、综合收益总额 | -33,315,080.47 | 26,476,516.01 | 15,086,624.93 | 11,223,395.23 |
| 归属于母公司股东的综合收益总额 | -32,708,167.29 | 28,288,283.49 | 15,988,537.87 | 11,482,340.18 |
| 归属于少数股东的综合收益总额 | -606,913.18 | -1,811,767.48 | -901,912.94 | -258,944.95 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-31 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |